These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10419838)

  • 1. Pharmacokinetic/pharmacodynamic modelling of the eosinopenic and hypokalemic effects of formoterol and theophylline combination in healthy men.
    van den Berg BT; Derks MG; Koolen MG; Braat MC; Butter JJ; van Boxtel CJ
    Pulm Pharmacol Ther; 1999; 12(3):185-92. PubMed ID: 10419838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and effects of formoterol fumarate in healthy human subjects after oral dosing.
    van den Berg BT; Braat MC; van Boxtel CJ
    Eur J Clin Pharmacol; 1998 Aug; 54(6):463-8. PubMed ID: 9776436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions.
    Derks MG; van den Berg BT; van der Zee JS; Braat MC; van Boxtel CJ
    J Pharmacol Exp Ther; 1997 Nov; 283(2):824-32. PubMed ID: 9353404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease.
    Kharidia J; Fogarty CM; Laforce CF; Maier G; Hsu R; Dunnington KM; Curry L; Baumgartner RA; Hanrahan JP
    Pulm Pharmacol Ther; 2008 Aug; 21(4):657-62. PubMed ID: 18501650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
    Dahl R; Creemers JP; Van Noord J; Sips A; Della Cioppa G; Thomson M; Andriano K; Kottakis J; Fashola T
    Respiration; 2004; 71(2):126-33. PubMed ID: 15031566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized formoterol fumarate: Dose selection and pharmacokinetics.
    Gross NJ; Kerwin E; Levine B; Kim KT; Denis-Mize K; Hamzavi M; Carpenter M; Rinehart M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):818-23. PubMed ID: 18655841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M; Arvidsson P; Beckman O; Peterson S; Lötvall J
    Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.
    Tornøe CW; Agersø H; Jonsson EN; Madsen H; Nielsen HA
    Comput Methods Programs Biomed; 2004 Oct; 76(1):31-40. PubMed ID: 15313540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.
    Murdoch RD; Zussman B; Schofield JP; Webber DM
    J Clin Pharmacol; 2004 Sep; 44(9):1046-53. PubMed ID: 15317832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
    Eklund A; Tronde A; Johannes-Hellberg I; Gillen M; Borgström L
    Biopharm Drug Dispos; 2008 Oct; 29(7):382-95. PubMed ID: 18623040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts.
    Spoelstra FM; Kauffman HF; Hovenga H; Noordhoek JA; de Monchy JG; Postma DS
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1229-34. PubMed ID: 11029322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
    Kaae R; Agertoft L; Pedersen S; Nordvall SL; Pedroletti C; Bengtsson T; Johannes-Hellberg I; Rosenborg J
    Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass balance and metabolism of [(3)H]Formoterol in healthy men after combined i.v. and oral administration-mimicking inhalation.
    Rosenborg J; Larsson P; Tegnér K; Hallström G
    Drug Metab Dispos; 1999 Oct; 27(10):1104-16. PubMed ID: 10497135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma.
    Kruse M; Rosenkranz B; Dobson C; Ayre G; Horowitz A
    Pulm Pharmacol Ther; 2005; 18(3):229-34. PubMed ID: 15707858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
    Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of theophylline-induced eosinopenia and hypokalaemia in healthy volunteers.
    Braat MC; Jonkers RE; Bel EH; Van Boxtel CJ
    Clin Pharmacokinet; 1992 Mar; 22(3):231-7. PubMed ID: 1559313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.